Aayush Wellness Ltd
Incorporated in 1984, Aayush Wellness Ltd provides nutraceutical, personalized health
care, preventive wellness, and digital health solutions[1]
- Market Cap ₹ 164 Cr.
- Current Price ₹ 33.6
- High / Low ₹ 267 / 26.9
- Stock P/E 36.4
- Book Value ₹ 2.19
- Dividend Yield 0.07 %
- ROCE 51.0 %
- ROE 51.1 %
- Face Value ₹ 1.00
Pros
Cons
- Stock is trading at 15.4 times its book value
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.1.97 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 5 | 100 | 188 | 132 | 127 | 152 | 17 | 8 | 1 | 73 | 129 | |
| 0 | 0 | 5 | 100 | 187 | 132 | 126 | 150 | 19 | 9 | 0 | 70 | 127 | |
| Operating Profit | -0 | -0 | -0 | 0 | 1 | -0 | 2 | 2 | -2 | -1 | 0 | 3 | 3 |
| OPM % | -33% | -29% | -4% | 0% | 0% | -0% | 1% | 1% | -11% | -10% | 58% | 5% | 2% |
| 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 2 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | -0 | 0 | 0 | 1 | 1 | 1 | 1 | -2 | -0 | 1 | 3 | 4 |
| Tax % | -50% | 0% | 36% | 25% | 25% | 26% | 27% | -1% | 0% | 3% | 0% | ||
| 0 | -0 | 0 | 0 | 1 | 1 | 1 | 0 | -2 | -0 | 1 | 3 | 4 | |
| EPS in Rs | 0.00 | -0.00 | 0.02 | 0.07 | 0.14 | 0.12 | 0.13 | 0.09 | -0.42 | -0.07 | 0.12 | 0.69 | 0.93 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 100% |
| 5 Years: | -10% |
| 3 Years: | 62% |
| TTM: | 154% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 79% |
| 5 Years: | 40% |
| 3 Years: | 54% |
| TTM: | 114% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 77% |
| 3 Years: | 191% |
| 1 Year: | -47% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | 22% |
| Last Year: | 51% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.25 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 5 | 5 |
| Reserves | 0 | 1 | 1 | 1 | 2 | 3 | 3 | 4 | 2 | 1 | 2 | 3 | 6 |
| 0 | 0 | 0 | 1 | 0 | 1 | 12 | 2 | 5 | 0 | 0 | 0 | 4 | |
| 0 | -0 | 1 | 11 | 37 | 29 | 29 | 27 | 1 | 0 | 0 | 0 | 0 | |
| Total Liabilities | 0 | 4 | 6 | 16 | 43 | 35 | 46 | 36 | 11 | 4 | 5 | 9 | 15 |
| 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 4 | 5 | 16 | 42 | 34 | 46 | 36 | 11 | 4 | 5 | 9 | 15 | |
| Total Assets | 0 | 4 | 6 | 16 | 43 | 35 | 46 | 36 | 11 | 4 | 5 | 9 | 15 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4 | -0 | -1 | 6 | -3 | -10 | 6 | -3 | 5 | -1 | 0 | ||
| 0 | 0 | 0 | -1 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | ||
| 4 | 0 | 1 | -1 | 1 | 11 | -9 | 3 | -5 | 0 | 0 | ||
| Net Cash Flow | 0 | -0 | 0 | 4 | -2 | 1 | -3 | 0 | -0 | -1 | 0 | |
| Free Cash Flow | -4 | -0 | -1 | 5 | -3 | -10 | 6 | -2 | 5 | -1 | 0 | |
| CFO/OP | 18,150% | 42% | -465% | 738% | 3,100% | -528% | 321% | 140% | -573% | -160% | 11% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 361 | 50 | 36 | 65 | 10 | 58 | 61 | 59 | 12 | 1 |
| Inventory Days | 0 | 0 | 7 | 37 | 23 | 120 | 25 | 136 | 0 | 1 | ||
| Days Payable | 45 | 78 | 83 | 89 | 72 | 17 | 1 | |||||
| Cash Conversion Cycle | 0 | 0 | 361 | 11 | -6 | 5 | 40 | 11 | 180 | 59 | 12 | 1 |
| Working Capital Days | 973 | 19,293 | 277 | 17 | -1 | 9 | 40 | 19 | 181 | 96 | 268 | 3 |
| ROCE % | 0% | -1% | 2% | 12% | 23% | 20% | 15% | 14% | -15% | -5% | 13% | 51% |
Insights
In beta| Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations (Agri-Commodity & Wellness) INR Lakhs |
|
|||||||||
| Trade Receivable Turnover Ratio x |
||||||||||
| Employee Count Number |
||||||||||
| Foreign Exchange Earnings USD |
||||||||||
| Number of Diagnostic Tests (Health ATM) Number |
||||||||||
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Change in Directorate
31 Mar - Appointed Dinesh Dhangare (DIN 11418438) and Kashiram Jadhav (DIN 11640980) as Additional Non-Executive Non-Independent Directors, 31 Mar 2026.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, 31St March 2026.
31 Mar - Appointed Dinesh Dhangare and Kashiram Jadhav as additional non-executive directors on 31 March 2026.
-
Closure of Trading Window
25 Mar - Trading window closed from April 1, 2026; reopens 48 hours after audited financial results declaration.
-
Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
14 Feb - A J M S & Co. LLP resigned as statutory auditor effective Feb 14, 2026; replacement pending.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Feb - Newspaper Advertisement pertaining to the Unaudited Financial Results for the quarter and nine months ended 31 December 2025
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
AWL provides comprehensive healthcare solutions and nutritional support. It has an integrated platform where individuals can access a wide range of health and wellness solutions tailored to their unique needs through AWL's Online Doctor Consultations, Nutritional Support Programs and Health Awareness Campaigns